U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Guidelines and Recommendations

CDC Stacks Public Health Publications

CDC Guidelines and Recommendations are updated by various CDC centers and institutes in response to new scientific discoveries, to public health issues, and to disease outbreaks. Items in this collection may have been superceded or replaced. For the most up to date information, please visit the CDC home page at https://www.cdc.gov/ and search the Health Topic or Outbreak you are interested in.

(5)
(2)
(4)
(3)
(8)
(3)
(17)
(10)
(16)
(13)
(27)
(33)
(21)
(46)
(33)
(34)
(34)
(23)
(25)
(18)
(19)
(27)
(21)
(29)
(13)
(15)
(17)
(14)
(12)
(10)
(13)
(15)
(12)
(14)
(11)
(16)
(16)
(6)
(1)
(3)
(3)
(6)
(3)
(1)
(4)
(27)
(22)
(30)
(8)
(9)
(7)
(7)
0 of 52
(123)
(27)
(1)
(1)
(633)
0 of 5
(7)
(1)
(3)
(8)
(7)
(31)
(1)
(10)
(7)
(3)
(13)
(1)
(1)
(1)
(1)
(105)
(1)
(1)
(7)
(3)
(2)
(1)
(1)
(6)
(49)
(2)
(121)
(14)
(55)
(2)
(30)
(6)
(4)
(1)
(7)
(1)
(2)
(404)
(2)
(6)
(13)
(2)
(1)
0 of 43
(7)
(2)
(40)
(3)
(2)
(2)
(7)
0 of 7
(53)
(6)
(5)
(1)
(3)
(12)
(564)
(1)
(1)
(28)
(41)
(63)
0 of 12
(455)
(1)
(31)
(270)
(1)
0 of 5
(130)
(18)
0 of 2
(138)
(9)
(1)
0 of 3
(2)
(1)
(9)
(8)
(6)
(2)
(1)
(1)
(1)
(1)
(16)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(2)
(74)
(1)
(5)
(1)
(1)
(1)
(87)
(1)
(1)
(7)
(1)
(4)
(35)
(2)
(9)
(1)
(5)
(2)
(1)
(8)
(3)
(3)
(7)
(1)
(2)
(1)
(1)
(2)
(2)
(2)
(30)
(1)
(8)
(21)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(36)
(6)
(1)
(6)
(3)
(13)
(2)
(2)
(1)
(5)
(1)
(1)
(2)
(1)
(8)
(1)
(2)
(1)
(8)
(1)
(3)
(3)
(1)
(8)
(5)
(1)
(1)
(2)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(14)
(3)
(1)
(4)
(1)
(2)
(1)
(3)
(6)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(6)
(10)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(8)
(1)
(1)
(1)
(4)
(2)
(4)
(9)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(2)
(6)
(2)
(4)
(5)
(1)
(2)
(13)
(1)
(1)
(2)
(1)
(4)
(6)
(2)
(2)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(22)
(2)
(13)
(3)
(1)
(2)
(1)
(4)
(2)
(4)
(1)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(6)
(3)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(6)
(2)
(2)
(1)
(92)
(76)
(3)
(1)
(1)
(1)
(2)
(4)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(11)
(2)
(3)
(3)
(3)
(2)
(2)
(6)
(2)
(3)
(9)
(2)
(5)
(2)
(3)
(4)
(14)
(3)
(2)
(10)
(4)
(3)
(7)
(3)
(4)
(6)
(2)
(2)
(2)
(2)
(12)
(2)
(2)
(10)
(3)
(2)
(4)
(4)
(5)
(3)
(2)
(2)
(2)
(11)
(10)
(2)
(15)
(6)
(3)
(3)
(2)
(3)
(2)
(5)
(3)
(3)
(2)
(7)
(2)
(2)
(2)
(3)
(3)
(2)
(8)
(5)
(2)
(2)
(2)
(2)
(2)
(3)
(10)
(10)
(2)
(2)
(2)
(3)
(2)
(21)
(2)
(4)
(2)
(6)
(30)
(20)
(18)
(2)
(5)
(2)
(7)
(3)
(2)
(5)
(8)
(2)
(2)
(3)
(7)
(2)
(2)
(5)
(3)
(2)
(9)
(11)
(2)
(3)
(2)
(2)
(4)
(7)
(6)
(6)
(2)
(2)
(2)
(4)
(3)
(2)
(25)
(2)
(15)
(2)
(3)
(5)
(32)
(2)
(2)
(5)
(2)
(3)
(15)
(2)
(3)
(5)
(4)
(7)
(2)
(2)
(2)
(4)
(4)
(6)
(3)
(5)
(3)
(4)
(3)
(4)
(64)
(2)
(3)
(3)
(2)
(3)
(2)
(2)
(2)
(4)
(3)
(2)
(3)
(4)
(2)
(3)
(2)
(2)
(2)
(4)
(2)
(4)
(2)
(3)
(3)
(2)
(2)
(2)
(6)
(3)
(13)
(8)
(2)
(78)
(3)
(12)
(7)
(3)
(4)
(21)
(2)
(3)
(5)
(13)
(4)
(2)
(2)
(2)
(3)
(3)
(2)
(5)
(5)
(4)
(2)
(5)
(3)
(3)
(3)
(2)
(4)
(2)
(8)
(4)
(2)
(2)
(8)
(4)
(5)
(2)
(2)
(2)
(2)
(10)
(7)
(6)
(2)
(3)
(3)
(43)
(2)
(3)
(2)
(4)
(2)
(5)
(2)
(2)
(11)
(11)
(6)
(4)
(6)
(6)
(6)
(2)
(2)
(2)
(5)
(221)
(12)
(2)
(2)
(2)
(2)
(10)
(7)
(2)
(18)
(2)
(2)
(7)
(7)
(4)
(9)
(98)
(2)
(2)
(10)
(2)
(2)
(4)
(2)
(3)
(5)
(83)
(30)
(2)
(31)
(7)
(2)
(8)
(2)
(7)
(3)
(4)
(5)
(20)
(10)
(9)
(3)
(14)
(6)
(2)
(12)
(4)
(11)
(2)
(10)
(2)
(16)
(5)
(2)
(2)
(21)
(18)
(3)
(8)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(3)
(5)
(3)
(3)
(5)
(2)
(2)
(10)
(2)
(5)
(12)
(2)
(5)
(2)
(3)
(2)
(14)
(3)
(3)
(3)
(2)
(3)
(3)
(2)
(5)
(2)
(4)
(2)
(2)
(13)
(3)
(4)
(4)
(11)
(11)
(2)
(42)
(4)
(29)
(2)
(2)
(16)
(3)
(9)
(5)
(8)
(9)
(2)
(2)
(9)
(15)
(2)
(11)
(7)
(2)
(2)
(2)
(3)
(43)
(2)
(6)
(4)
(2)
(4)
(8)
(8)
(8)
(5)
(2)
(9)
(6)
(7)
(2)
(2)
(4)
(3)
(6)
(2)
(2)
(27)
(2)
(140)
(167)
(2)
(4)
(3)
(2)
(2)
(5)
(6)
(7)
(4)
(4)
(10)
(4)
(11)
(5)
(6)
(5)
(2)
(2)
(36)
(5)
(4)
(2)
(2)
(4)
(2)
(4)
(4)
(10)
(3)
(2)
(4)
(2)
(11)
(2)
(2)
(5)
(2)
(3)
(5)
(23)
(3)
(6)
(2)
(2)
(3)
(2)
(22)
(6)
(3)
(60)
(3)
(23)
(2)
(4)
(5)
(2)
(2)
(2)
(6)
(2)
(2)
(2)
(17)
(2)
(2)
(2)
(6)
(2)
(13)
(2)
(16)
(5)
(5)
(4)
(4)
(3)
(24)
(9)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(7)
(3)
(2)
(18)
(2)
(2)
(16)
(3)
(3)
(10)
(2)
(6)
(2)
(7)
(3)
(2)
(3)
(5)
(7)
(10)
(2)
(18)
(22)
(5)
(3)
(2)
(7)
(12)
(31)
(41)
(3)
(4)
(2)
(2)
(2)
(3)
(2)
(3)
(5)
(166)
(24)
(7)
(3)
(3)
(10)
(2)
(6)
(2)
(2)
(3)
(2)
(7)
(2)
(4)
(6)
(2)
(2)
(2)
(2)
(17)
(3)
(4)
(2)
(5)
(3)
(2)
(2)
(7)
(3)
(2)
(13)
(5)
(6)
(2)
(4)
(2)
(2)
(2)
(2)
(4)
(19)
(15)
(7)
(3)
(6)
(4)
(3)
(2)
(3)
(3)
(3)
(2)
(4)
(2)
(2)
(2)
(2)
(5)
(3)
(2)
(3)
(5)
(3)
(2)
(2)
(2)
(4)
(4)
(6)
(3)
(3)
(2)
(2)
(6)
(2)
(2)
(2)
(37)
(2)
(2)
(14)
(2)
(2)
(2)
(8)
(19)
(3)
(5)
(4)
(2)
(4)
(6)
(2)
(2)
(2)
(3)
(3)
(3)
(2)
(6)
(10)
(87)
(2)
(23)
(15)
(2)
(8)
(16)
(11)
(11)
(15)
(2)
(12)
(2)
(3)
(3)
(5)
(14)
(3)
(2)
(2)
(6)
(4)
(5)
(4)
(8)
(6)
(3)
(4)
(2)
(2)
(10)
(3)
(2)
(2)
(3)
(9)
(2)
(12)
(4)
(5)
(2)
(2)
(2)
(2)
(2)
(17)
(5)
(4)
(3)
0 of 1000
(4)
(2)
(1)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(8)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(13)
(1)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(11)
(1)
(1)
(3)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(1)
(2)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(22)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(2)
(1)
(4)
(1)
(9)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(6)
(1)
(1)
(10)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(4)
(1)
(3)
(2)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(8)
(1)
(2)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(2)
(1)
(3)
(5)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(2)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(4)
(2)
(1)
(2)
(3)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(5)
(1)
(4)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(7)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(7)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(5)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(4)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(3)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(3)
(4)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(2)
(2)
(1)
(3)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(6)
(2)
(2)
(2)
(7)
(2)
(5)
(3)
(4)
(3)
(2)
(7)
(2)
(2)
(5)
(2)
(2)
(5)
(6)
(2)
(2)
(3)
(3)
(4)
(3)
(3)
(4)
(2)
(5)
(3)
(4)
(2)
(2)
(2)
(2)
(2)
(5)
(9)
(2)
(3)
(2)
(2)
(2)
(2)
(2)
(7)
(3)
(2)
(6)
(2)
(2)
(2)
(3)
(2)
(3)
(2)
(6)
(4)
(2)
(5)
(5)
(8)
(2)
(2)
(4)
(3)
(3)
0 of 1000
(1)
(6)
(1)
(3)
(19)
(1)
(3)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(12)
(17)
(8)
(1)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(6)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(26)
(1)
(2)
(1)
(1)
(4)
(22)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(269)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(6)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(13)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(11)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(2)
(3)
(2)
(1)
(1)
(3)
(1)
(4)
(2)
(4)
(5)
(2)
(5)
(2)
(3)
(1)
(19)
(1)
(3)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(8)
(1)
(1)
(2)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(4)
(1)
(1)
(1)
(1)
(10)
(1)
(3)
(1)
(4)
(4)
(4)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(1)
(7)
(6)
(4)
(9)
(17)
(2)
(1)
(1)
(1)
(4)
(6)
(1)
(4)
(3)
(1)
(1)
(1)
(4)
(1)
(1)
(15)
(6)
(2)
(1)
(1)
(1)
(1)
(1)
(5)
(2)
(1)
(1)
(4)
(1)
(2)
(1)
(8)
(1)
(2)
(1)
(1)
(1)
(1)
(6)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(8)
(3)
(7)
(1)
(1)
(142)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(8)
(1)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(2)
(12)
(122)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(9)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
0 of 436
(1)
(1)
(9)
(4)
(1)
(1)
(8)
(91)
(3)
(2)
(47)
(224)
(1)
(25)
(1)
(80)
(1)
(25)
(2)
(5)
(145)
(1)
(1)
(4)
(1)
(4)
0 of 26
(2)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(6)
(1)
(1)
(1)
(1)
(6)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(6)
(2)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
0 of 191
Showing 241 - 260 of 786 results
  • Joint statement on bed bug control in the United States from the US Centers for Disease Control and Prevention CDC and the US Environmental Protection Agency EPA
    Joint statement on bed bug control in the United States from the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Environmental Protection Agency (EPA)
    Centers for Disease Control and Prevention (U.S.)  ...
    2010
    The Centers for Disease Control and Prevention (CDC) and the U.S. Environmental Protection Agency (EPA) developed this document to highlight emerging public health issues associated with bed bugs (Cimex lectularius) in communities throughout the United States.Suggested citation: Centers for Disease Control and Prevention and U.S. Environmental Prot ...
    Current Public Domain
  • Advice for travelers
    Advice for travelers
    Centers for Disease Control and Prevention (U.S.)  ...
    November 2009 | Treatment guidelines from the Medical Letter. 2009; 7(87):83-94; quiz 2 p following 94.
    Treatment Guidelines from The Medical Letter . Patients planning to travel to other countries often ask physicians for information about appropriate vaccines and prevention of diarrhea and malaria. More detailed advice for travelers is available from the Centers for Disease Control and Prevention (CDC) at www.cdc.gov/travel. Guidelines are also ava ...
    Public Domain
  • Preventing dental caries through schoolbased sealant programs updated recommendations and reviews of evidence
    Preventing dental caries through school-based sealant programs: updated recommendations and reviews of evidence.
    November 2009 | Journal of the American Dental Association (1939). 2009; 140(11):1356-65.
    BACKGROUND: School-based sealant programs (SBSPs) increase sealant use and reduce caries. Programs target schools that serve children from low-income families and focus on sealing newly erupted permanent molars. In 2004 and 2005, the Centers for Disease Control and Prevention (CDC), Atlanta, sponsored meetings of an expert work group to update reco ...
    Current Public Domain
  • Evaluation for Improvement A SevenStep Empowerment Evaluation Approach for Violence Prevention Organizations
    Evaluation for Improvement: A Seven-Step Empowerment Evaluation Approach for Violence Prevention Organizations
    Cox, Pamela J. ;
    Craft, Carole A.
    November 2009
    "This manual is designed to help violence prevention organizations hire an empowerment evaluator who will assist them in building their evaluation capacity through a learn-by-doing process of evaluating their own strategies. It is for state and local leaders and staff members of organizations, coalitions, government agencies, and/or partnerships wo ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports October 16 2009 Vol 58 No RR12
    Morbidity and Mortality Weekly Report: Recommendations and Reports, October 16, 2009 / Vol. 58 / No. RR-12
    Gould, L. Hannah ;
    Bopp, Cheryl
    October 16, 2009 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    "Shiga toxin--producing Escherichia coli (STEC) are a leading cause of bacterial enteric infections in the United States. Prompt, accurate diagnosis of STEC infection is important because appropriate treatment early in the course of infection might decrease the risk for serious complications such as renal damage and improve overall patient outcome. ...
    Current Public Domain
  • ACCFAHAACP 2009 Competence and Training Statement A Curriculum on Prevention of Cardiovascular Disease
    ACCF/AHA/ACP 2009 Competence and Training Statement: A Curriculum on Prevention of Cardiovascular Disease
    American College of Sports Medicine .  ...
    September 29, 2009 | Circulation. 2009; 120(13):e100-26.
    The American College of Cardiology Foundation (ACCF)/American Heart Association (AHA)/American College of Physicians (ACP) Task Force on Clinical Competence was formed in 1998 to develop recommendations for attaining and maintaining the cognitive and technical skills necessary for the competent performance of a specific cardiovascular service, proc ...
    Current Public Domain
  • Updated Recommendation from the Advisory Committee on Immunization Practices ACIP for Revaccination of Persons at Prolonged Increased Risk for Meningococcal Disease
    Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Revaccination of Persons at Prolonged Increased Risk for Meningococcal Disease
    United States. Advisory Committee on Immunization Practices.
    September 25, 2009 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    The Advisory Committee on Immunization Practices (ACIP) recommends quadrivalent meningococcal conjugate vaccine, (MCV4) (Menactra, Sanofi Pasteur, Swiftwater, Pennsylvania) for all persons aged 11-18 years and for persons aged 2-55 years at increased risk for meningococcal disease. MCV4 is licensed as a single dose. Because of the high risk for men ...
    Superseded Public Domain
  • Licensure of a Haemophilus influenzae type b Hib Vaccine Hiberix and updated recommendations for use of Hib vaccine
    Licensure of a Haemophilus influenzae type b (Hib) Vaccine (Hiberix) and updated recommendations for use of Hib vaccine
    September 18, 2009 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    On August 19, 2009, the Food and Drug Administration (FDA) licensed Hiberix (GlaxoSmithKline Biologicals, Rixensart, Belgium), a Haemophilus influenzae type b (Hib) conjugate vaccine composed of H. influenzae type b capsular polysaccharide (polyribosyl-ribitol-phosphate [PRP]) conjugated to inactivated tetanus toxoid (PRP-T). Hiberix is licensed fo ...
    Current Supporting Files Public Domain
  • Updated Recommendations from the Advisory Committee on Immunization Practices ACIP for Use of Hepatitis A Vaccine in Close Contacts of newly Arriving International Adoptees
    Updated Recommendations from the Advisory Committee on Immunization Practices (ACIP) for Use of Hepatitis A Vaccine in Close Contacts of newly Arriving International Adoptees
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Viral Hepatitis.  ...
    September 18, 2009 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    On February 25, 2009, the Advisory Committee on Immunization Practices (ACIP) recommended routine hepatitis A vaccination for household members and other close personal contacts (e.g., regular babysitters) of adopted children newly arriving from countries with high or intermediate hepatitis A endemicity. This new recommendation complements previous ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports August 28 2009 Vol 58 No RR10
    Morbidity and Mortality Weekly Report: Recommendations and Reports, August 28, 2009 / Vol. 58 / No. RR-10
    United States. Advisory Committee on Immunization Practices.  ...
    August 28, 2009 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    "This report provides recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of vaccine against infection with novel influenza A (H1N1) virus. Information on vaccination for seasonal influenza has been published previously (CDC. Prevention and control of seasonal influenza with vaccines: recommendations of th ...
    Superseded Public Domain
  • Updated Recommendations of the Advisory Committee on Immunization Practices ACIP regarding routine poliovirus vaccination
    Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination
    United States. Advisory Committee on Immunization Practices.
    August 7, 2009 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    This report updates Advisory Committee on Immunization Practices (ACIP) recommendations for routine poliovirus vaccination. These updates aim to 1) emphasize the importance of the booster dose at age >/=4 years, 2) extend the minimum interval from dose 3 to dose 4 from 4 weeks to 6 months, 3) add a precaution for the use of minimum intervals in the ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports August 7 2009 Vol 58 No RR9
    Morbidity and Mortality Weekly Report: Recommendations and Reports, August 7, 2009 / Vol. 58 / No. RR-9
    Brown, Mary Jean ;
    Wengrovitz, Anne M.
    August 7, 2009 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    "Lead is a potent, pervasive neurotoxicant, and elevated blood lead levels (EBLLs) can result in decreased IQ, academic failure, and behavioral problems in children. Eliminating EBLLs among children is one of the 2010 U.S. national health objectives. Data from the National Health and Nutrition Examination Survey (NHANES) indicate substantial decrea ...
    Current Public Domain
  • The Scientific Foundation for personal genomics recommendations from a National Institutes of HealthCenters for Disease Control and Prevention multidisciplinary workshop
    The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop
    United States. National Institutes of Health.  ...
    August 2009 | Genetics in medicine : official journal of the American College of Medical Genetics. 2009; 11(8):559-67.
    The increasing availability of personal genomic tests has led to discussions about the validity and utility of such tests and the balance of benefits and harms. A multidisciplinary workshop was convened by the National Institutes of Health and the Centers for Disease Control and Prevention to review the scientific foundation for using personal geno ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports July 31 2009 Vol 58 No RR8
    Morbidity and Mortality Weekly Report: Recommendations and Reports, July 31, 2009 / Vol. 58 / No. RR-8
    Bresee, Joseph S. ;
    Broder, Karen R.
    July 31, 2009 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    This report updates the 2008 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine for the prevention and control of seasonal influenza (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2008;57[No. RR-7]). Informat ...
    Superseded Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports July 24 2009 Vol 58 No RR7
    Morbidity and Mortality Weekly Report: Recommendations and Reports, July 24, 2009 / Vol. 58 / No. RR-7
    Khan, Laura Kettel ;
    Sobush, Kathleen
    July 24, 2009 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    "Approximately two thirds of U.S. adults and one fifth of U.S. children are obese or overweight. During 1980-2004, obesity prevalence among U.S. adults doubled, and recent data indicate an estimated 33% of U.S. adults are overweight (body mass index [BMI] 25.0-29.9), 34% are obese (BMI >=30.0), including nearly 6% who are extremely obese (BMI >=40. ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports July 12 2009 Vol 58 No RR6
    Morbidity and Mortality Weekly Report: Recommendations and Reports, July 12, 2009 / Vol. 58 / No. RR-6
    Chen, Bin ;
    Gagnon, MariBeth C.
    July 12, 2009 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    "Under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations, laboratory testing is categorized as waived (from routine regulatory oversight) or nonwaived based on the complexity of the tests; tests of moderate and high complexity are nonwaived tests. Laboratories that perform molecular genetic testing are subject to the general ...
    Current Public Domain
  • Current Intelligence Bulletin 61 A Strategy for Assigning New NIOSH Skin Notations
    Current Intelligence Bulletin 61: A Strategy for Assigning New NIOSH Skin Notations
    Ahlers, Heinz W. ;
    Chen, Chen-Peng
    2009/07/01 | NIOSH Numbered Publications
    This document has been superseded and the new version can be found https://www.cdc.gov/niosh/docs/2009-147/. NIOSH skin notations are hazard warnings used worldwide to alert workers and employers to the health risks of skin exposures to chemicals in the workplace. This Current Intelligence Bulletin (CIB) provides the rationale for assigning new NIO ...
    Current Public Domain
  • Updated Recommendations for use of Haemophilus influenzae Type b Hib Vaccine Reinstatement of the Booster Dose at Ages 1215 Months
    Updated Recommendations for use of Haemophilus influenzae Type b (Hib) Vaccine: Reinstatement of the Booster Dose at Ages 12-15 Months
    United States. Advisory Committee on Immunization Practices.  ...
    June 26, 2009 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    On December 13, 2007, certain lots of Haemophilus influenzae type b (Hib) vaccine marketed as PedvaxHIB (monovalent Hib vaccine) and Comvax (Hib-HepB vaccine), and manufactured by Merck & Co., Inc., were recalled voluntarily, and the company temporarily suspended production of these vaccines. To conserve the limited supply of Hib-containing vaccine ...
    Retired Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports May 1 2009 Vol 58 No RR5
    Morbidity and Mortality Weekly Report: Recommendations and Reports, May 1, 2009 / Vol. 58 / No. RR-5
    National Association of State Public Health Veterinarians (U.S.)  ...
    May 1, 2009 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    "This report provides recommendations for public health officials, veterinarians, animal venue staff members, animal exhibitors, visitors to animal venues, physicians, and others concerned with minimizing risks associated with animals in public settings. The recommendation to wash hands is the most important prevention step for reducing the risk fo ...
    Superseded Public Domain
  • FDA Approval of Expanded Age Indication for a Tetanus Toxoid Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
    FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
    Centers for Disease Control and Prevention (U.S.)
    April 17, 2009 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    On December 4, 2008, the Food and Drug Administration (FDA) approved an expanded age indication for the tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) Boostrix (GlaxoSmithKline Biologicals, Rixensart, Belgium). Boostrix is now licensed for use in persons aged 10--64 years as a single-dose booster immunization; the ...
    Superseded Supporting Files Public Domain
241 - 260 / 786